All In MedTech

FDA Clearance Tracker · P150031-S076

Vercise™ DBS Controller

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 5, 2025

Approved

Time to decision

215 days

Received Jul 5, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150031-S076
Device name
Vercise™ DBS Controller
Applicant location
Valencia, CA
Received
Jul 5, 2024
Decided
Feb 5, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150031

Device type

Device class
Class III

Every decision under product code NHL

FDA's approval statement

As written in FDA's record.

approval for the Vercise™ DBS Controller, a mobile application intended to function as an alternate to the current Vercise™ Remote Control (RC) 4 (approved in P150031/S034) to control the Vercise Genus DBS Implantable Pulse Generator (IPG) and External Trial Stimulator (ETS)

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.